Saxon Interests Inc. Grows Stock Holdings in CME Group Inc. (NASDAQ:CME)

Saxon Interests Inc. lifted its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 12.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,803 shares of the financial services provider’s stock after acquiring an additional 642 shares during the period. Saxon Interests Inc.’s holdings in CME Group were worth $1,280,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. Salomon & Ludwin LLC acquired a new stake in CME Group during the first quarter worth about $28,000. Y.D. More Investments Ltd bought a new stake in CME Group in the 2nd quarter valued at about $36,000. McClarren Financial Advisors Inc. boosted its stake in CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the period. Asset Dedication LLC boosted its stake in CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares during the period. Finally, Rise Advisors LLC acquired a new stake in shares of CME Group in the first quarter valued at approximately $41,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

CME has been the topic of a number of recent analyst reports. Citigroup lifted their price objective on shares of CME Group from $240.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. The Goldman Sachs Group upped their price target on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research note on Thursday, October 3rd. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a report on Tuesday. JPMorgan Chase & Co. increased their price target on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research report on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $217.71.

Read Our Latest Analysis on CME Group

CME Group Stock Up 0.0 %

CME stock traded up $0.06 during trading hours on Wednesday, hitting $221.74. The company’s stock had a trading volume of 462,277 shares, compared to its average volume of 1,958,269. The company has a market capitalization of $79.84 billion, a PE ratio of 25.22, a price-to-earnings-growth ratio of 8.74 and a beta of 0.55. The stock has a 50 day moving average price of $213.12 and a two-hundred day moving average price of $207.73. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $226.78.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The company had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.30 earnings per share. On average, equities research analysts expect that CME Group Inc. will post 9.94 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.07%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Insider Transactions at CME Group

In related news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. In related news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.